Categoria: Healthcare

Poultry Diagnostics Market 2023 | Industry Size, Share, Trends and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled, “Poultry Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global poultry diagnostics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the poultry diagnostics market?

The global poultry diagnostics market size reached US$ 441.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 791.2 Million by 2028, exhibiting a growth rate (CAGR) of 10.2% during 2023-2028.

What is poultry diagnostics?

Poultry diagnostics is used to identify various diseases in birds, such as avian polyomavirus (AI), west Nile virus, and poxvirus infections. It involves the systematic examination of body organs through various techniques, such as clinical assessment and molecular diagnostic testing, to provide appropriate treatment. It also includes quality testing of different feed ingredients like fish meal, meat meal, and ground-nut cake for preventing food infectivity and improving production efficiency.  As a result, it is gaining immense traction among farmers as poultry diagnostics helps ensure proper growth, increases production, and assists poultry dealers in making herd management decisions by identifying different pathogens.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/poultry-diagnostics-market/requestsample

What are the growth prospects and trends in the poultry diagnostics industry?

The increasing number of poultry farms is resulting in the rising prevalence of infectious diseases, such as chronic respiratory disease (CRD), infectious bronchitis (IB), chicken anemia (CA), and newcastle disease (ND). This represents one of the key factors positively influencing the market. Rapid detection and diagnostics decrease further transmission, reduce costs, and help eradicate, eliminate, and control foodborne pathogens using natural antimicrobials. In addition, the increasing global population and the escalating demand for poultry-derived food products, such as eggs and meat, due to the rising awareness among people about the health benefits of consuming poultry is providing a thrust to the market growth. Furthermore, active support from governmental and non-governmental organizations (NGOs) in various countries to prevent the spread of zoonotic diseases is positively influencing the market. In addition, the implementation of stringent health and food safety regulations by regulatory authorities and improvement in laboratory testing of human and animal health to detect and respond to emerging health threats effectively is strengthening the market growth. In addition, the integration of advanced technologies, such as artificial intelligence (AI) and big data analytics, for real-time analysis tools that utilize audio and visual components and assess poultry health is creating a favorable market outlook. Moreover, the introduction of enzyme-linked immunosorbent assay (ELISA) to detect antibodies or antigens in chickens is offering lucrative growth opportunities for manufacturers to develop better testing tools for diagnostics. Apart from this, the increasing use of poultry feathers in composites, electronic devices, nano- and micro-particles, and tissue engineering scaffolds is catalyzing the demand for poultry diagnostics. Besides this, leading players are extensively investing in research and development (R&D) activities to introduce advanced tools and imaging for better diagnosis. They are also focusing on incorporating biosensors, wearable sensors, and robot vehicle surveillance to monitor the health of birds, which is expected to drive the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Disease Type:

  • Avian Influenza
  • Avian Salmonellosis
  • Avian Mycoplasmosis
  • Infectious Bronchitis
  • Infectious Bursal Disease
  • Newcastle Disease
  • Chicken Anemia
  • Others

Breakup by Test Type:

  • ELISA test
  • PCR Test
  • Others

Breakup by Service:

  • Bacteriology
  • Parasitology
  • Virology

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AgroBioTek Laboratories
  • BioChek BV
  • Bionote Co. Ltd.
  • Boehringer Ingelheim International GmbH
  • IDEXX Laboratories Inc.
  • MEGACOR Diagnostik GmbH
  • QIAGEN N.V
  • Royal GD
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

Ask Customization report: https://www.imarcgroup.com/request?type=report&id=4381&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800

United States Wound Care Market 2023 | Industry Size, Share and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled, “United States Wound Care Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the United States wound care market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the United States wound care market?

The United States wound care market is projected to exhibit a growth rate (CAGR) of 4.25% during 2023-2028.

What is wound care?

Wound care involves meticulously managing wounds to promote healing and prevent complications. It includes practices to treat various types of wounds, including cuts, burns, surgical incisions, and chronic ulcers. It involves cleaning the wound, applying appropriate dressings, and ensuring a sterile environment to minimize the risk of infection. Additionally, healthcare professionals employ techniques such as debridement, removing dead tissue, suturing, or using advanced wound care products depending on the severity and type of wound. It is also essential to seek medical attention for serious wounds and receive proper treatment and guidance for ongoing care, while effective wound care accelerates the healing process and reduces the likelihood of scarring and infection.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/united-states-wound-care-market/requestsample

What are the growth prospects and trends in the United States wound care industry?

The United States wound care market is primarily driven by the growing incidences of chronic ailments such as obesity, cardiovascular diseases, and diabetes. In addition, the increasing geriatric population susceptible to chronic wounds requires advanced wound care solutions for proper management and healing, thus escalating the demand for effective wound care products, which influences market growth. Moreover, several technological innovations and advanced wound care products, such as bioactive dressings, negative pressure wound therapy (NPWT) systems, and wound healing devices, represent another major growth-inducing factor. Besides this, these innovations accelerate the wound healing process, minimize infection risks, and enhance patient comfort, thus accelerating the market growth. Furthermore, the integration of technologies such as telemedicine and wearable wound monitoring devices further improves patient care by allowing healthcare providers to monitor wound progress and intervene, when necessary, thus creating a positive market outlook.

What is included in market segmentation?

The report has segmented the market into the following categories:

Product Type Insights:

  • Advance Wound Care Products
    • Foam Dressing
    • Hydrocolloid Dressing
    • Film Dressing
    • Alginate Dressing
    • Hydrogel Dressing
    • Collagen Dressing
    • Others
  • Surgical Wound Care Products
    • Sutures
    • Staplers
    • Tissue Adhesive, Sealants & Hemostats
    • Anti-Effective Dressing
  • Traditional Wound Care Products
    • Medical Tapes
    • Cleansing Agent
  • Active Wound Care Products
    • Biological Skin Substitutes
    • Topical Agents
  • Wound Therapy Devices Products
    • Negative Pressure Wound Therapy
    • Oxygen and Hyperbaric Oxygen Equipment
    • Electric Stimulation Devices
    • Pressure Relief Devices
    • Wound Assessment & Monitoring Devices
    • Others

Wound Type Insights:

  • Chronic Wounds
    • Diabetics Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Others
  • Acute Wounds
    • Surgical Traumatic Wounds
    • Burns

End User Insights:

  • Hospitals & Clinics
  • Long-Term Care Facilities
  • Home Care Setting
  • Others

Breakup by Region:

  • Northeast
  • Midwest
  • South
  • West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Analyst for Customized Report: https://www.imarcgroup.com/request?type=report&id=11067&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Bioprocess Bags Market 2023 | Industry Trends, Size and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled, “Bioprocess Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global bioprocess bags market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the bioprocess bags market?

The global bioprocess bags market size reached US$ 2.93 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.6 Billion by 2028, exhibiting a growth rate (CAGR) of 17.10% during 2023-2028.

What is bioprocess bags?

A bioprocess bag is a critical component in biopharmaceutical manufacturing and bioengineering processes, designed to store and transport bioproducts, media, and other biological substances. These bags are usually made from medical-grade plastic. They are flexible, single-use containers essential in maintaining the sterile conditions necessary for effective bioprocessing. They are designed to withstand a range of temperatures and mechanical stresses, ensuring the preservation and viability of the biological materials contained within. As a result, bioprocess bags find extensive applications in the biopharmaceutical sector, including in the production of vaccines, therapeutic proteins, monoclonal antibodies, cell therapy products, and other biologics. These bags are instrumental in bioreactors, storage, and freezing systems, mixing systems, and cell culture operations, promoting safer and more efficient biopharmaceutical manufacturing practices.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/bioprocess-bags-market/requestsample

What are the growth prospects and trends in the bioprocess bags industry?

The global bioprocess bags market is primarily driven by the increasing demand for biopharmaceutical products around the world due to an aging population and the rising prevalence of chronic diseases. Besides this, there is a rise in the need for efficient and scalable bioprocessing solutions, which has augmented the demand for bioprocess bags. Additionally, the development of novel therapeutic entities, such as cell and gene therapies, and the escalating adoption of bioprocessing in regenerative medicine are positively influencing market growth. In line with this, the shifting inclination toward single-use technologies in biopharmaceutical manufacturing to reduce cross-contamination risks and operational costs is accelerating the adoption of single-use bioprocess bags. Moreover, the emerging trend toward outsourcing bioproduction to contract manufacturing organizations (CMOs) is contributing to market growth. Along with this, ongoing technological innovations and the introduction of more durable, high-capacity bags are opening new opportunities in the market. For instance, the advent of smart bioprocess bags equipped with sensors and wireless communication capabilities has enabled real-time monitoring and enhanced process control. Furthermore, regulatory bodies worldwide are imposing stringent standards and norms to ensure the safety and efficacy of biopharmaceutical products. These strict regulations necessitate the use of sterile and reliable bioprocessing solutions like bioprocess bags, thereby contributing to market growth. Apart from this, the increasing number of biotech startups usually rely on single-use bioprocess technologies, such as bioprocess bags, to minimize initial capital expenditure and accelerate time to market. In line with this, the growing focus on sustainability and the reduction of environmental impact is promoting the adoption of single-use technologies such as bioprocess bags. Other factors, including the development of personalized medicine and targeted therapies, the rapid expansion of healthcare infrastructure, hefty investments and government support, and research activities in life science sectors, are also expected to propel the market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Type Insights:

  • 2D Bioprocess Bags
  • 3D Bioprocess Bags
  • Other Bags and Accessories

Workflow Insights:

  • Upstream Process
  • Downstream Process
  • Process Development
  • Others

End User Insights:

  • Pharmaceutical and Biopharmaceutical Companies
  • CMOs and CROs
  • Academic and Research Institutes
  • Others

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Charter Medical Ltd. (Solesis Medical Technologies Inc.)
  • Compagnie de Saint-Gobain S.A.
  • Danaher Corporation
  • Entegris Inc
  • FlexBiosys Inc. (Repligen Corporation)
  • ILC Dover LP, Indutrade AB
  • PROAnalytics LLC
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8308&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Dapsone Manufacturing Plant Project Report 2023 | Plant Cost and Raw Material Requirement

How to Set a Dapsone Manufacturing Plant:

IMARC Group’s report titled “Dapsone Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue” provides a comprehensive guide for establishing a dapsone manufacturing unit. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the operational aspects, the report also provides in-depth insights into project economics, encompassing vital aspects such as capital investments, project funding, operating expenses, income and expenditure projections, fixed and variable costs, direct and indirect expenses, expected ROI, net present value (NPV), profit and loss account, and thorough financial analysis, among other crucial metrics. With this comprehensive roadmap, entrepreneurs and stakeholders can make informed decisions and navigate the path toward a successful dapsone manufacturing venture.

Dapsone Manufacturing Plant:

Dapsone, a remarkable pharmaceutical compound, stands as a testament to the intersection of medical innovation and the quest to alleviate human suffering. This synthetic sulfone has showcased its efficacy not only in combating infectious diseases but also in managing inflammatory and immunological conditions. Dapsone’s mechanism of action, primarily attributed to its antimicrobial and anti-inflammatory properties, has contributed to its adoption across diverse medical fields. From leprosy and dermatological disorders to autoimmune conditions, its pharmacological versatility underscores its importance within modern medicine.

Request for a sample copy of the report: https://www.imarcgroup.com/dapsone-manufacturing-plant-project-report/requestsample

Trends and Drivers:

The dapsone market is driven by a synergy of pivotal market drivers and emerging trends within the pharmaceutical and medical domains. Originally recognized for its effectiveness against leprosy, dapsone’s diverse clinical applications now span dermatological disorders like acne and inflammatory conditions such as dermatitis herpetiformis. This versatility, along with its affordability, underpins its demand in both developed and developing healthcare systems. An evolving trend involves the exploration of combination therapies, where dapsone’s role as an adjunct to other treatments enhances its efficacy. Additionally, the rise of personalized medicine is influencing its utilization, tailoring doses to individual patient characteristics. Yet, challenges persist, including the potential for adverse reactions and the need for vigilant monitoring. Research endeavors are focused on optimizing treatment regimens and understanding potential mechanisms of resistance. In conclusion, the dapsone market thrives due to its multi-faceted clinical applications, affordability, and adaptability to modern treatment approaches. As healthcare landscapes evolve, dapsone’s role continues to unfold, driven by the convergence of medical advancements and patient-centric care.

Report Coverage: The project report includes the following information:

Market Analysis Coverage:  

  • Market Trends
  • Breakup by Segment
  • Breakup by Region
  • Price Analysis
  • Impact of COVID-19
  • Market Forecast

Detailed Process Flow: 

  • Product Overview
  • Unit Operations Involved
  • Mass Balance and Raw Material Requirements
  • Quality Assurance Criteria
  • Technical Tests

Project Details, Requirements and Costs Involved:  

  • Land, Location and Site Development
  • Plant Layout
  • Machinery Requirements and Costs
  • Raw Material Requirements and Costs
  • Packaging Requirements and Costs
  • Transportation Requirements and Costs
  • Utility Requirements and Costs
  • Human Resource Requirements and Costs

Project Economics:  

  • Capital Investments
  • Operating Costs
  • Expenditure Projections
  • Revenue Projections
  • Taxation and Depreciation
  • Profit Projections
  • Financial Analysis

Purchase completion report: https://www.imarcgroup.com/checkout?id=10617&method=247

What Key Questions Does This Project Report Address?

  • How has the dapsone market performed so far and how will it perform in the coming years?
  • What is the market segmentation of the global dapsone market?
  • What is the regional breakup of the global dapsone market?
  • What are the price trends of various feedstocks in the dapsone industry?
  • What is the structure of the dapsone industry and who are the key players?
  • What are the various unit operations involved in a dapsone manufacturing plant?
  • What is the total size of land required for setting up a dapsone manufacturing plant?
  • What is the layout of a dapsone manufacturing plant?
  • What are the machinery requirements for setting up a dapsone manufacturing plant?
  • What are the raw material requirements for setting up a dapsone manufacturing plant?
  • What are the packaging requirements for setting up a dapsone manufacturing plant?
  • What are the transportation requirements for setting up a dapsone manufacturing plant?
  • What are the utility requirements for setting up a dapsone manufacturing plant?
  • What are the human resource requirements for setting up a dapsone manufacturing plant?
  • What are the infrastructure costs for setting up a dapsone manufacturing plant?
  • What are the capital costs for setting up a dapsone manufacturing plant?
  • What are the operating costs for setting up a dapsone manufacturing plant?
  • What should be the pricing mechanism of the final product?
  • What will be the income and expenditures for a dapsone manufacturing plant?
  • What is the time required to break even?
  • What are the profit projections for setting up a dapsone manufacturing plant?
  • What are the key success and risk factors in the dapsone industry?
  • What are the key regulatory procedures and requirements for setting up a dapsone manufacturing plant?
  • What are the key certifications required for setting up a dapsone manufacturing plant?

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Allergy Relieving Eye Drops Market 2023 | Industry Size, Share and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled, “Allergy Relieving Eye Drops Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global allergy relieving eye drops market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the allergy relieving eye drops market?

The global allergy relieving eye drops market size reached US$ 1.26 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.79 Billion by 2028, exhibiting a growth rate (CAGR) of 5.86% during 2023-2028.

What is allergy relieving eye drops?

Allergy-relieving eye drops, also known as antihistamine eye drops, are pharmaceutical solutions designed to alleviate the symptoms of eye allergies. These symptoms often include itching, redness, watering, and irritation caused by the body’s immune response to allergens such as pollen, pet dander, or dust mites. Allergy-relieving eye drops work by blocking the effects of histamine, a chemical released by the body during an allergic reaction, thereby reducing inflammation and soothing discomfort. These drops provide targeted relief to the eyes, helping to alleviate the symptoms associated with allergic reactions. At present, allergy-relieving eye drops are available over the counter and in prescription-strength formulations across the globe, catering to individuals seeking effective and rapid relief from eye allergies, enhancing their overall comfort and well-being.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/allergy-relieving-eye-drops-market/requestsample

What are the growth prospects and trends in the allergy relieving eye drops industry?

The global allergy relieving eye drops market is primarily driven by the rising prevalence of allergies due to factors such as pollen, dust, and pet dander. Additionally, the heightening awareness about eye health and the availability of over-the-counter and prescription-strength allergy-relieving eye drops have catalyzed market growth. Moreover, the advancement of medical research and technology, including the development of innovative formulations that offer rapid and long-lasting relief from discomfort caused by allergic reactions, is propelling market growth. Furthermore, the increasing eye irritants owing to changing lifestyles, rapid urbanization, and various environmental factors has escalated the need for reliable remedies, thereby contributing to market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Drug Class:

  • Antihistamines
  • Non-steroidal Anti-Inflammatory Drugs
  • Vasoconstrictors
  • Others

Breakup by Type:

  • Seasonal and Perennial Allergic Conjunctivitis
  • Vernal Keratoconjunctivitis
  • Atopic Keratoconjunctivitis
  • Giant Papillary Conjunctivitis

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Johnson & Johnson
  • Rohto Pharmaceutical Co. Ltd.
  • Santen Pharmaceutical Co. Ltd.
  • Similasan Corporation

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=9848&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Europe Health Insurance Market 2023 | Industry Share, Size and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled, “Europe Health Insurance Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the Europe health insurance market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Europe health insurance market?

The Europe health insurance market is projected to exhibit a growth rate (CAGR) of 5.6% during 2023-2028.

What is health insurance?

Health insurance is a financial arrangement that provides individuals or groups with coverage for medical expenses and healthcare services. It is a contract between the policyholder and an insurance company wherein the insured pays regular premiums. In return, the insurer agrees to cover a portion of the medical costs incurred by the insured. It reduces the financial burden of unexpected medical expenses and promote access to quality healthcare. Various types of health insurance plans available are individual health insurance, family health insurance, and group health insurance offered by employers. Each plan provides specific benefits and coverage levels tailored to the needs of the policyholders. Some common services covered by health insurance include hospitalization, doctor’s visits, prescription medications, preventive care, and diagnostic tests. Health insurance operates on the principle of risk pooling, where the contributions from numerous policyholders create a pool of funds to bear medical expenses for those in need. It allows individuals to share the financial risk associated with healthcare costs, making medical services more affordable and accessible. It also encourages timely medical attention and preventive care and promotes a healthier society overall, as people seek necessary medical treatment when they have adequate insurance coverage. As a result, health insurance is gaining immense traction in Europe, providing comprehensive coverage and access to quality healthcare for millions of individuals.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/europe-health-insurance-market/requestsample

What are the growth prospects and trends in the Europe health insurance industry?

The Europe health insurance market is primarily driven by the escalating demand for healthcare services due to the aging population and increasing life expectancy. Moreover, the widespread prevalence of chronic diseases and the escalating cost of medical treatments have augmented the demand for health insurance solutions to manage healthcare expenses effectively. Apart from this, various regulatory frameworks and government policies, including countries implementing several healthcare reforms to improve access and affordability, have accelerated the product adoption rate. Additionally, numerous technological advancements in the healthcare sector, such as telemedicine and digital health solutions, encourage insurers to adapt and offer innovative coverage options, thereby propelling the market growth. Besides this, insurance providers are offering personalized and wellness-focused products owing to changing consumer preferences and heightened awareness about the importance of health and well-being, which in turn has catalyzed market growth. Furthermore, the rising adoption of digital services amid the coronavirus (COVID-19) pandemic and an emerging sense of financial security among individuals are contributing to the market growth. Other factors, including increasing medical tourism across European countries, the advent of new and specialized treatments, and growing emphasis on mental health awareness, are also anticipated to drive the market further in the coming years.

What is included in market segmentation?

The report has segmented the market into the following categories:

Provider Insights:

  • Private Providers
  • Public Providers

Type Insights:

  • Life-Time Coverage
  • Term Insurance

Plan Type Insights:

  • Medical Insurance
  • Critical Illness Insurance
  • Family Floater Health Insurance
  • Others

Demographics Insights:

  • Minor
  • Adults
  • Senior Citizen

Provider Type Insights:

  • Preferred Provider Organizations (PPOs)
  • Point of Service (POS)
  • Health Maintenance Organizations (HMOs)
  • Exclusive Provider Organizations (EPOs)

Breakup by Region:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=9109&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Poultry Diagnostics Market 2023 | Industry Size, Share and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled, “Poultry Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global poultry diagnostics market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the poultry diagnostics market?

Report Attributes Details
Market Size in 2022 US$ 441.8 Million
Market Forecast in 2028 US$ 791.2 Million
Growth rate (2023 to 2028) CAGR of 10.2%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is poultry diagnostics?

Poultry diagnostics comprise several tests conducted to diagnose poultry diseases accurately. It typically includes toxicology, clinical examination, pathology, molecular diagnostic testing, and quality assurance testing of feed ingredients to prevent infectious diseases and food infection in waterfowl, chickens, broilers, ducks, and turkeys. It helps poultry farmers to identify, prevent and treat numerous diseases such as chronic respiratory disease (CRD), infectious bronchitis (IB), avian influenza (AI), Newcastle disease (ND), and avian salmonellosis, and chicken anemia (CA) that can occur due to their lack of proper care and management and inadequate nutritious feeding of poultry birds. As a result, poultry diagnostics are widely adopted in veterinary diagnostic centers, hospitals, and clinics across the globe.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/poultry-diagnostics-market/requestsample

What are the growth prospects and trends in the poultry diagnostics industry?

The market is primarily driven by the increasing incidences of zoonotic diseases. Additionally, the increasing poultry disease outbreaks such as avian influenza, avian mycoplasmosis, and infectious bursal disease, and the rising concerns regarding food security are contributing to the market growth. Presently, the continuous efforts to raise awareness regarding these diseases caused by numerous fungi, viruses, bacteria, protozoon pathogens, nutritional deficiencies, and environmental stress are influencing market growth. Moreover, the implementation of strict health and food safety standards and numerous favorable initiatives undertaken by governing and non-governing organizations (NGOs) to generate awareness regarding infectious diseases among poultry farmers represents another major growth-inducing factor. Besides this, the escalating demand for poultry-derived food products such as meat and eggs and the increasing awareness about the advantages of early detection of diseases and available treatment options are propelling the market growth. Along with this, the widespread adoption of enzyme-linked immunosorbent assay (ELISA) tests due to their high accuracy, sensitivity, and cost-efficiency is accelerating the product adoption rate. Additionally, the development of advanced testing tools and point of care (POC) diagnostics for newer illnesses such as mortality syndrome are providing a positive thrust to the market growth. Apart from this, the poultry diagnostics market is growing at different rates in numerous regions, with North America being one of the largest markets due to the increasing consumer awareness regarding food safety, rising consumption of poultry-derived products, and growing incidence of zoonotic diseases associated with poultry across the region. Moreover, the industry is expected to face competition in the upcoming years as numerous key players are implementing competitive strategies to sustain their presence in the market. For instance, in February 2018, BioChek introduced Avian Influenza H5-H7-H9 Multiplex, a PCR testing kit for diagnosing influenza in poultry. Furthermore, new product launches, extensive research and development (R&D) activities, and mergers and acquisitions (M&A) among key market players are creating a positive global market outlook. For instance, in July 2018, Zoetis acquired Abaxis, a global player in veterinary point-of-care testing instruments, to maintain its position in veterinary diagnosis.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Disease Type:

  • Avian Influenza
  • Avian Salmonellosis
  • Avian Mycoplasmosis
  • Infectious Bronchitis
  • Infectious Bursal Disease
  • Newcastle Disease
  • Chicken Anemia
  • Others

Breakup by Test Type:

  • ELISA test
  • PCR Test
  • Others

Breakup by Service:

  • Bacteriology
  • Parasitology
  • Virology

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AgroBioTek Laboratories
  • BioChek BV
  • Bionote Co. Ltd.
  • Boehringer Ingelheim International GmbH
  • IDEXX Laboratories Inc.
  • MEGACOR Diagnostik GmbH
  • QIAGEN N.V
  • Royal GD
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

Ask Analyst for Customized Report: https://www.imarcgroup.com/request?type=report&id=4381&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Medical Billing Outsourcing Market 2023 | Industry Size and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled, ” Medical Billing Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ” The study provides a detailed analysis of the industry, including the global medical billing outsourcing market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the medical billing outsourcing market?

Report Attributes Details
Market Size in 2022 US$ 9.1 Billion
Market Forecast in 2028 US$ 17.5 Billion
Growth rate (2023 to 2028) CAGR of 12.1%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is medical billing outsourcing?

Medical billing outsourcing is a practice where healthcare institutions or companies delegate their billing processes to external service providers. This approach aims to improve patient care and streamline hospital operations by efficiently managing staff and resources. By outsourcing billing tasks, the likelihood of errors is minimized, and accuracy is ensured through timely submissions. This practice not only saves costs but also expedites cash flow and enhances patient satisfaction. With its ability to facilitate faster insurance payments and promote transparency, medical billing outsourcing has become a prevalent solution adopted by hospitals and clinics worldwide.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/medical-billing-outsourcing-market/requestsample

What are the growth prospects and trends in the medical billing outsourcing industry?

The medical billing outsourcing market is experiencing significant growth driven by the increased adoption of information technology (IT) resources in the healthcare sector. This trend is strengthening the market as healthcare businesses recognize the advantages of outsourcing their billing processes. Additionally, the growing number of patients and the need for efficient record and billing management are fueling the demand for medical billing outsourcing services. The market is further propelled by regulations mandating digital record-keeping in the healthcare industry. Government agencies’ investments in healthcare infrastructure also contribute to the market’s expansion. Furthermore, the growing awareness among the public about the benefits of medical billing outsourcing in minimizing errors is playing a crucial role in driving market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Market Breakup by Type:

  • In-House
  • Outsourced

Market Breakup by Service:

  • Front End
  • Middle End
  • Back End

Market Breakup by End-Use:

  • Hospitals
  • Physician Offices
  • Others

Market Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Accretive Health (R1 RCM Inc.)
  • Allscripts
  • Cerner Corporation
  • EClinicalWorks
  • Experian Information Solutions Inc.
  • GE Healthcare
  • Genpact
  • HCL Technologies
  • Kareo
  • McKesson Corporation
  • Quest Diagnostics, etc.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=1946&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Gene Panel Market 2023 | Industry Trends, Size and Forecast 2028

According to the latest report by IMARC Group, titled, “Gene Panel Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global gene panel market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the gene panel market?

Report Attributes Details
Market Size in 2022 US$ 864.75 Million
Market Forecast in 2028 US$ 2,233.06 Million
Growth rate (2023 to 2028) CAGR of 16.3%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is gene panel?

Gene panel refers to a laboratory test used to analyze a set of genes with variants known to be associated with the development of a disease or a collection of clinical symptoms under investigation. It aids in detecting mutations in specific genes in a tissue sample that may increase the risk of a disorder, including cancer, in an individual. Gene panel sequencing is usually performed using next-generation sequencing (NGS) technology. Compared to sequential single-gene sequencing, whole-exome sequencing (WES), and whole-genome sequencing (WGS), gene panel is faster and more cost-effective. It is gaining immense traction across the globe.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/gene-panel-market/requestsample

What are the growth prospects and trends in the gene panel industry?

The increasing incidences of hereditary disorders and cancer are primarily driving the gene panel market. Furthermore, the escalating demand for efficient diagnostic methods among clinicians to understand the genetic predisposition of any cancer or other known genetic disorders to determine better disease prognostics and therapeutics is also augmenting the market growth. Apart from this, the growing popularity of predesigned and customizable gene panels and direct-to-consumer genetic testing kits that do not require wide laboratory setup or personnel is positively influencing the global market. Moreover, numerous biopharmaceutical and biotechnology companies are investing in extensive research and development (R&D) activities to introduce targeted therapies for cancer treatment, which is further bolstering the market growth. Besides this, the rising need for gene panels in pre-gestational, prenatal, and neonatal screening procedures is acting as another significant growth-inducing factor. Additionally, the launch of screening programs by government bodies of several countries and continuous technological advancements in diagnostics services and methods are expected to drive the gene panel market in the coming years.

What is included in market segmentation?

The report has segmented the market into the following categories:

Products and Services Insights:

  • Test Kits
  • Testing Services

Technique Insights:

  • Amplicon-based Approach
  • Hybridization-based Approach

Design Insights:

  • Predesigned Gene Panel
  • Customized Gene Panel

Application Insights:

  • Cancer Risk Assessment
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Others

End User Insights:

  • Academic and Research Institutes
  • Hospital and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Agilent Technologies Inc.
  • BGI Genomics Co. Ltd. (BGI Group)
  • Eurofins Scientific SE
  • Hoffmann-La Roche AG
  • Genewiz LLC (Azenta Inc.)
  • Illumina Inc.
  • Integrated DNA Technologies Inc. (Danaher Corporation)
  • Novogene Co. Ltd.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc., etc.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8105&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Cloning & Mutagenesis Market 2023 | Industry Size, Trends and Forecast 2028

According to the latest report by IMARC Group, titled, “Cloning & Mutagenesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global cloning & mutagenesis market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the cloning & mutagenesis market?

Report Attributes Details
Market Size in 2022 US$ 2.4 Billion
Market Forecast in 2028 US$ 6.4 Billion
Growth rate (2023 to 2028) CAGR of 17.3%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is cloning & mutagenesis?

Cloning and mutagenesis refer to two crucial techniques used in the field of biotechnology. Cloning represents the process of making an identical copy of a Deoxyribonucleic Acid (DNA) sequence, typically using a vector (including a plasmid) to insert the sequence into a host organism (such as bacteria). On the other hand, mutagenesis is often utilized to study the function of specific genes or to create new variants with altered properties. In recent times, these important techniques have gained traction as they are critical tools that have revolutionized numerous areas of biotechnology and have enabled researchers to study genes and proteins for the development of novel therapeutics, agricultural products, and industrial processes.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/cloning-mutagenesis-market/requestsample

What are the growth prospects and trends in the cloning & mutagenesis industry?

The growing prevalence of chronic and genetic disorders across the globe is primarily driving the cloning and mutagenesis market. Furthermore, the escalating demand for personalized medicines as they involve tailoring medical treatment to an individual genetic makeup, which is performed through these crucial techniques, is also augmenting the market growth. Apart from this, the widespread adoption of cloning and mutagenesis in the biotechnology and pharmaceutical industries to develop new drugs, vaccines, and therapeutic proteins is positively influencing the global market. Moreover, several advancements in genetic engineering technologies that have made these important techniques more efficient, precise, and cost-effective are further bolstering the market growth. Besides this, the increasing applications of genetically modified organisms (GMOs) in agriculture for producing insect-resistant and herbicide-tolerant seeds and in the medical industry are acting as significant growth-inducing factors. Additionally, government bodies of various countries and private organizations are investing in research and development (R&D) in the biotechnology field, which is expected to drive the cloning and mutagenesis market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Product Insights:

  • Cloning Kits
  • Mutagenesis Kits

Technology Insights:

  • Topo PCR Cloning
  • Blunt End Cloning
  • Seamless Cloning
  • Site-directed Mutagenesis
  • Others

End User Insights:

  • Biopharmaceutical and Pharmaceutical Companies
  • CROs and CMOs
  • Academic and Research Institutes

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • ABM Industries Inc.
  • Agilent Technologies Inc.
  • Assay Genie Limited
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International Inc. (Bausch & Lomb)
  • Genewiz Inc (Azenta Life Sciences)
  • Jena Bioscience GmbH
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co. Ltd., etc.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8110&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group